New Topic for Discussion: Manufacture's Reports
I would like to open a new area for discussion. It revolves around the idea that more recent information will released about "L" in the next 2 weeks.
We know for certain that a. the trial was expanded, b. the screening of new patients was suspended, c. the trial was down-sized from 348 to 331 patients, and patients are still being treated with either "L" or a placebo or both.
If we do get new information in 2 weeks, could it include information from the manufacturing sites?
Like: They know when first vac/pla was manufactured. b. they know where treatments were sent to. c. they know how many treatments were sent where. d. they know if a second request was sent to deliver the true vac. because of the 'cross-over" e. they know (by coded reference) when no more vac/pla was requested (patient probably progressed or died) f. they know every time a vac/pla was requested. they know about the compassionate use patients.
My question to all the followers is> How much information might be released by the company on the information that is already known, but has not been reported on?
Because this is a revolutionary treatment that is completely personalized, each patient is followed and reported on to the manufacturer. Even though the manufacturer does not know who gets the true vaccine and who gets the placebo, they know how many true vaccines and how many placebos they manufactured. Yes, we have down-sized the trial, so it will not be exactly 2/3 to 1/3rd but the company has said it thinks it will be OK. Is that because it has looked at the type of #'s I have raised and see that patients are "all living longer"?
What is your best guess? Will we get some indication soon about PFC #s and OS#s and can they (will they) bring other information to the shareholders about what is known by the manufactures? Thank you. I am long and loyal and hoping for the future of cancer treatment we will succeed before something really complex derails us. GLTA
